Total Payments
$1,976
2024 Payments
$662.57
Companies
21
Transactions
51
Medicare Patients
804
Medicare Billing
$83,881
Payment Breakdown by Category
Food & Beverage$1,976 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,976 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $351.35 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $247.60 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $245.79 | 2 | $0 (2022) |
| Horizon Therapeutics plc | $189.99 | 5 | $0 (2023) |
| Novo Nordisk Inc | $131.57 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $106.30 | 4 | $0 (2024) |
| Abbott Laboratories | $105.17 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $104.49 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $97.25 | 3 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $84.81 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $662.57 | 19 | Amgen Inc. ($351.35) |
| 2023 | $464.86 | 17 | Horizon Therapeutics plc ($189.99) |
| 2022 | $197.27 | 5 | GlaxoSmithKline, LLC. ($124.98) |
| 2021 | $360.99 | 4 | GlaxoSmithKline, LLC. ($120.81) |
| 2020 | $19.54 | 1 | Aroa Biosurgery Incorporated ($19.54) |
| 2019 | $148.59 | 2 | Janssen Pharmaceuticals, Inc ($112.92) |
| 2018 | $121.85 | 3 | Novo Nordisk Inc ($88.24) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: NEPHROLOGY | ||||||
| 05/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/17/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $105.17 | General |
| Category: Vascular | ||||||
| 03/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: DIABETES | ||||||
| 01/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Diabetes | ||||||
| 01/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $84.81 | General |
| Category: Cardio-renal | ||||||
| 01/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/30/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: KRYSTEXXA | ||||||
| 11/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: DIABETES | ||||||
| 11/07/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $43.88 | General |
| 11/02/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: DIABETES | ||||||
| 10/02/2023 | LeMaitre Vascular, Inc. | ARTEGRAFT VASCULAR GRAFT (Device) | Food and Beverage | Cash or cash equivalent | $16.77 | General |
| Category: ARTEGRAFT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 177 | 285 | $67,914 | $22,576 |
| 2022 | 4 | 180 | 249 | $58,632 | $20,932 |
| 2021 | 6 | 261 | 307 | $64,009 | $26,316 |
| 2020 | 6 | 186 | 293 | $40,929 | $14,057 |
Total Patients
804
Total Services
1,134
Medicare Billing
$83,881
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 130 | $24,050 | $7,601 | 31.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 26 | $15,250 | $4,362 | 28.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 35 | $7,239 | $3,262 | 45.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 47 | $7,260 | $2,841 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,875 | $2,679 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 24 | $6,240 | $1,831 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 130 | $24,770 | $8,499 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $22,280 | $8,015 | 36.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 40 | $8,142 | $3,099 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $3,440 | $1,319 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 110 | $16,500 | $7,838 | 47.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $19,430 | $7,717 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 66 | $14,520 | $6,351 | 43.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 31 | $6,293 | $2,463 | 39.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $7,146 | $1,864 | 26.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 21 | 24 | $120.00 | $83.52 | 69.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 36 | 55 | $11,165 | $4,528 | 40.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 48 | $10,560 | $3,913 | 37.1% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 60 | 144 | $12,240 | $2,843 | 23.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $4,764 | $2,037 | 42.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 14 | $2,100 | $666.91 | 31.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 19 | 20 | $100.00 | $69.53 | 69.5% |
About Nirav Parikh
Nirav Parikh is a Internal Medicine healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1811331184.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nirav Parikh has received a total of $1,976 in payments from pharmaceutical and medical device companies, with $662.57 received in 2024. These payments were reported across 51 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,976).
As a Medicare-enrolled provider, Parikh has provided services to 804 Medicare beneficiaries, totaling 1,134 services with total Medicare billing of $83,881. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Gainesville, GA
- Active Since 04/17/2013
- Last Updated 12/17/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811331184
Products in Payments
- KRYSTEXXA (Biological) $541.34
- XARELTO (Drug) $247.60
- TRELEGY ELLIPTA (Drug) $120.81
- Ozempic (Drug) $110.34
- MITRACLIP (Device) $105.17
- Andexxa (Drug) $104.49
- JYNARQUE (Drug) $85.66
- Kerendia (Drug) $84.81
- LOKELMA (Drug) $77.43
- JARDIANCE (Drug) $71.12
- VYNDAQEL (Drug) $48.64
- CARDIVA VASCADE 6/7F VCS (Device) $32.18
- BELSOMRA (Drug) $21.36
- Rybelsus (Drug) $21.23
- BREATHTEK (Device) $20.64
- FARXIGA (Drug) $19.82
- ARTEGRAFT VASCULAR GRAFT (Device) $16.77
- DALVANCE (Drug) $16.70
- TARPEYO (Drug) $14.87
- PREVENA (Device) $13.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gainesville
Dr. Vivek Sambhara, M.d, M.D
Internal Medicine — Payments: $217,213
Internal Medicine $217,213
Dr. Christopher Recknor, M.d, M.D
Internal Medicine — Payments: $91,144
Internal Medicine $91,144
Dr. Carlos Alviar Restrepo, Md, MD
Internal Medicine — Payments: $90,926
Internal Medicine $90,926
Dr. Alanna Morris, M.d, M.D
Internal Medicine — Payments: $85,602
Internal Medicine $85,602
Brian Ramnaraign, M.d, M.D
Internal Medicine — Payments: $65,740
Internal Medicine $65,740
Ilie Barb, M.d, M.D
Internal Medicine — Payments: $55,024
Internal Medicine $55,024